UK markets closed

Transgene SA (0OCQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.4761-0.0989 (-3.84%)
At close: 4:57PM BST
Currency in EUR

Valuation measures

Market cap (intra-day) 5154.44M
Enterprise value 3208.24M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)16.53
Price/book (mrq)4.12
Enterprise value/revenue 322.29
Enterprise value/EBITDA 7-9.26

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 3N/A
S&P500 52-week change 332.74%
52-week high 32.4761
52-week low 32.4498
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.28M
Implied shares outstanding 6N/A
Float 836.74M
% held by insiders 155.96%
% held by institutions 11.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020


Profit margin -184.43%
Operating margin (ttm)-258.94%

Management effectiveness

Return on assets (ttm)-15.05%
Return on equity (ttm)-29.72%

Income statement

Revenue (ttm)9.34M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-52.70%
Gross profit (ttm)-18M
EBITDA -22.48M
Net income avi to common (ttm)-17.23M
Diluted EPS (ttm)-0.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.35M
Total cash per share (mrq)0.31
Total debt (mrq)18.36M
Total debt/equity (mrq)36.54
Current ratio (mrq)2.25
Book value per share (mrq)0.60

Cash flow statement

Operating cash flow (ttm)-28.74M
Levered free cash flow (ttm)-15.52M